CLRB
Cellectar Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$17.82M
P/E Ratio
—
EPS
$-5.38
Beta
0.54
52W High
$12.13
52W Low
$2.20
50-Day MA
$2.86
200-Day MA
$3.52
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Cellectar Biosciences Inc
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development and commercialization of drugs for the treatment of cancer. The company is headquartered in Florham Park, New Jersey.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-22.16M |
| Operating Margin | 0.00% |
| Return on Equity | -290.40% |
| Return on Assets | -103.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.66 |
| Price-to-Book | 6.39 |
| Price-to-Sales (TTM) | 348.47 |
| EV/Revenue | 314.45 |
| EV/EBITDA | -3.25 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $7.99M |
| Float | $7.82M |
| % Insiders | 2.07% |
| % Institutions | 16.62% |
Historical Volatility
HV 10-Day
62.90%
HV 20-Day
56.39%
HV 30-Day
81.26%
HV 60-Day
67.05%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($10.33 target)
1
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026